{"id":1480,"date":"2020-03-11T16:56:01","date_gmt":"2020-03-11T15:56:01","guid":{"rendered":"http:\/\/wordpress.p545550.webspaceconfig.de\/gco_companies\/biontech-small-molecules-gmbh\/"},"modified":"2024-06-03T15:42:04","modified_gmt":"2024-06-03T13:42:04","slug":"biontech-small-molecules-gmbh","status":"publish","type":"gco_companies","link":"https:\/\/www.izb-online.de\/en\/unternehmen\/biontech-small-molecules-gmbh\/","title":{"rendered":"BioNTech SE, Munich Small Molecules"},"content":{"rendered":"<div class=\"wpb-content-wrapper\"><p>[vc_row][vc_column][\/vc_column][\/vc_row][vc_row el_class=&#8221;container-inner&#8221;][vc_column][vc_row_inner][vc_column_inner el_class=&#8221;gco-tmpl-company__image-column&#8221; width=&#8221;1\/2&#8243; offset=&#8221;vc_col-lg-4 vc_col-md-4&#8243;][vc_single_image image=&#8221;15769&#8243; img_size=&#8221;full&#8221; el_class=&#8221;gco-tmpl-company__image&#8221;][vc_column_text el_class=&#8221;gco-tmpl-company__image-info-copyright&#8221;]BioNTech SE[\/vc_column_text][vc_column_text el_class=&#8221;gco-tmpl-company__image-info-desc&#8221;]Dr. Sierk Poetting<br \/>\nCFO &amp; COO[\/vc_column_text][\/vc_column_inner][vc_column_inner width=&#8221;1\/2&#8243; offset=&#8221;vc_col-lg-8 vc_col-md-8&#8243;][vc_column_text el_class=&#8221;gco-company-post-heading&#8221;]<\/p>\n<h3>About BioNTech SE<\/h3>\n<p>[\/vc_column_text][vc_column_text]<\/p>\n<p style=\"text-align: left;\">BioNTech was founded in 2008 on the understanding that every cancer patient\u2019s tumor is unique and therefore each patient\u2019s treatment should be individualized. It is our goal to develop novel therapies for cancer and other serious diseases. As we prove the value of our approach in the clinic, we will continue to build the partnerships, manufacturing and team required to bring individualized treatments to patients worldwide. With roots in Mainz, Germany, we are driven to become the leading global biotechnology company for individualized cancer medicine. The team in Martinsried, which joined BioNTech in 2016, focuses on small molecules therapeutics. The product candidate BNT411, a chemically synthesized TLR7 agonist, is the first candidate being developed in Martinsried and just having entered clinical Phase 1.<\/p>\n<p>[\/vc_column_text][vc_column_text el_class=&#8221;gco-company-post-heading&#8221;]<\/p>\n<div class=\"page\" title=\"Page 1\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<h3>What is your motivation?<\/h3>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<p>[\/vc_column_text][vc_column_text css=&#8221;&#8221;]<\/p>\n<div class=\"page\" title=\"Page 1\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>We are pioneers in personalised immunotherapies, committed to revolutionising patient care. For decades, we have been combining groundbreaking immunology research with modern therapeutic platforms and bioinformatics tools to develop personalized treatments for cancer and other diseases. We believe that there is a better way to treat cancer. The interaction between cancer and the immune system is influenced by various patient-specific, tumor-specific, and environmental factors. This complex interplay affects the disease progression of each patient individually and guides the selection of the most appropriate treatment.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<p>[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][\/vc_column][\/vc_row][vc_row][vc_column width=&#8221;1\/2&#8243; offset=&#8221;vc_col-lg-4 vc_col-md-4&#8243;][\/vc_column][vc_column width=&#8221;1\/2&#8243; el_class=&#8221;gco-tmpl-company-quote&#8221; offset=&#8221;vc_col-lg-8 vc_col-md-8&#8243;][vc_column_text el_class=&#8221;gco-tmpl-company-quote__text&#8221;]\u201cWe aim to discover and develop the next generation of small molecule immunomodulatory compounds to improve the standard of care. The expertise of our colleagues in Martinsried is a key element to achieve this.\u201d[\/vc_column_text][vc_column_text el_class=&#8221;gco-tmpl-company-quote__source&#8221;]Dr. Sierk Poetting<br \/>\nCFO &amp; COO[\/vc_column_text][\/vc_column][\/vc_row][vc_row disable_element=&#8221;yes&#8221; el_class=&#8221;container-inner&#8221;][vc_column][vc_row_inner][vc_column_inner][vc_column_text el_class=&#8221;text-unternehmen&#8221;]Move in : 01\/01\/2017[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][\/vc_column][\/vc_row][vc_row][vc_column][vc_row_inner][vc_column_inner offset=&#8221;vc_hidden-lg vc_hidden-md vc_hidden-sm vc_hidden-xs&#8221;][vc_column_text el_class=&#8221;text-unternehmen&#8221;]<strong>Research:<\/strong>\u00a0 The department Munich Small Molecules (MSM) of BioNTech SE is focused on the identification, characterization and development of novel innovative small molecule compounds to be used as cancer therapeutics, especially in the field of immune oncology. Several of the drug candidates discovered in recent years have been developed through regulatory preclinics into clinical phases. MSM contains all important research units to maintain a sustainable project pipeline: computer based hit finding and lead optimization, medicinal chemistry, chem- and bioanalytics as well as formulation development. To ensure a complete characterization of drug candidates, we perform also pharmacokinetic and toxicological studies in house. Our activities are supported by a broad network of biologists and pharmacologists.<\/p>\n<p><strong>Services:<\/strong>\u00a0 As a department of BioNTech SE, MSM offers services throughout the complete discovery process. These drug discovery services encompass all research areas from the identification of initial hits to the selection of the preclinical drug development candidate. Special expertise can be provided in the fields of computational chemistry, medicinal chemistry, analytics, pharmacology and pharmacokinetics\/toxicology.[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][\/vc_column][\/vc_row]<\/p>\n<\/div>","protected":false},"featured_media":13330,"template":"","meta":{"_links_to":"","_links_to_target":""},"company-categories":[205],"class_list":["post-1480","gco_companies","type-gco_companies","status-publish","has-post-thumbnail","hentry","company-categories-startups-en"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v28.1 (Yoast SEO v28.1) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>BioNTech SE, Munich Small Molecules - Innovations- und Gr\u00fcnderzentrum Biotechnologie IZB<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.izb-online.de\/en\/unternehmen\/biontech-small-molecules-gmbh\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"BioNTech SE, Munich Small Molecules\" \/>\n<meta property=\"og:description\" content=\"BioNTech SEDr. Sierk Poetting CFO &amp; COO About BioNTech SE BioNTech was founded in 2008 on the understanding that every cancer patient\u2019s tumor is\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.izb-online.de\/en\/unternehmen\/biontech-small-molecules-gmbh\/\" \/>\n<meta property=\"og:site_name\" content=\"Innovations- und Gr\u00fcnderzentrum Biotechnologie IZB\" \/>\n<meta property=\"article:modified_time\" content=\"2024-06-03T13:42:04+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.izb-online.de\/wp-content\/uploads\/2020\/09\/biontec.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"400\" \/>\n\t<meta property=\"og:image:height\" content=\"89\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/unternehmen\\\/biontech-small-molecules-gmbh\\\/\",\"url\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/unternehmen\\\/biontech-small-molecules-gmbh\\\/\",\"name\":\"BioNTech SE, Munich Small Molecules - Innovations- und Gr\u00fcnderzentrum Biotechnologie IZB\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/unternehmen\\\/biontech-small-molecules-gmbh\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/unternehmen\\\/biontech-small-molecules-gmbh\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.izb-online.de\\\/wp-content\\\/uploads\\\/2020\\\/09\\\/biontec.jpg\",\"datePublished\":\"2020-03-11T15:56:01+00:00\",\"dateModified\":\"2024-06-03T13:42:04+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/unternehmen\\\/biontech-small-molecules-gmbh\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.izb-online.de\\\/en\\\/unternehmen\\\/biontech-small-molecules-gmbh\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/unternehmen\\\/biontech-small-molecules-gmbh\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.izb-online.de\\\/wp-content\\\/uploads\\\/2020\\\/09\\\/biontec.jpg\",\"contentUrl\":\"https:\\\/\\\/www.izb-online.de\\\/wp-content\\\/uploads\\\/2020\\\/09\\\/biontec.jpg\",\"width\":400,\"height\":89},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/unternehmen\\\/biontech-small-molecules-gmbh\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Startups im IZB\",\"item\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/company-categories\\\/startups-en\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"BioNTech SE, Munich Small Molecules\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/\",\"name\":\"Innovations- und Gr\u00fcnderzentrum Biotechnologie IZB\",\"description\":\"Innovations- und Gr\u00fcnderzentrum Biotechnologie\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/#organization\",\"name\":\"F\u00f6rdergesellschaft IZB mbH\",\"url\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.izb-online.de\\\/wp-content\\\/uploads\\\/2020\\\/06\\\/izb-logo.svg\",\"contentUrl\":\"https:\\\/\\\/www.izb-online.de\\\/wp-content\\\/uploads\\\/2020\\\/06\\\/izb-logo.svg\",\"width\":1,\"height\":1,\"caption\":\"F\u00f6rdergesellschaft IZB mbH\"},\"image\":{\"@id\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"BioNTech SE, Munich Small Molecules - Innovations- und Gr\u00fcnderzentrum Biotechnologie IZB","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.izb-online.de\/en\/unternehmen\/biontech-small-molecules-gmbh\/","og_locale":"en_US","og_type":"article","og_title":"BioNTech SE, Munich Small Molecules","og_description":"BioNTech SEDr. Sierk Poetting CFO &amp; COO About BioNTech SE BioNTech was founded in 2008 on the understanding that every cancer patient\u2019s tumor is","og_url":"https:\/\/www.izb-online.de\/en\/unternehmen\/biontech-small-molecules-gmbh\/","og_site_name":"Innovations- und Gr\u00fcnderzentrum Biotechnologie IZB","article_modified_time":"2024-06-03T13:42:04+00:00","og_image":[{"width":400,"height":89,"url":"https:\/\/www.izb-online.de\/wp-content\/uploads\/2020\/09\/biontec.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.izb-online.de\/en\/unternehmen\/biontech-small-molecules-gmbh\/","url":"https:\/\/www.izb-online.de\/en\/unternehmen\/biontech-small-molecules-gmbh\/","name":"BioNTech SE, Munich Small Molecules - Innovations- und Gr\u00fcnderzentrum Biotechnologie IZB","isPartOf":{"@id":"https:\/\/www.izb-online.de\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.izb-online.de\/en\/unternehmen\/biontech-small-molecules-gmbh\/#primaryimage"},"image":{"@id":"https:\/\/www.izb-online.de\/en\/unternehmen\/biontech-small-molecules-gmbh\/#primaryimage"},"thumbnailUrl":"https:\/\/www.izb-online.de\/wp-content\/uploads\/2020\/09\/biontec.jpg","datePublished":"2020-03-11T15:56:01+00:00","dateModified":"2024-06-03T13:42:04+00:00","breadcrumb":{"@id":"https:\/\/www.izb-online.de\/en\/unternehmen\/biontech-small-molecules-gmbh\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.izb-online.de\/en\/unternehmen\/biontech-small-molecules-gmbh\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.izb-online.de\/en\/unternehmen\/biontech-small-molecules-gmbh\/#primaryimage","url":"https:\/\/www.izb-online.de\/wp-content\/uploads\/2020\/09\/biontec.jpg","contentUrl":"https:\/\/www.izb-online.de\/wp-content\/uploads\/2020\/09\/biontec.jpg","width":400,"height":89},{"@type":"BreadcrumbList","@id":"https:\/\/www.izb-online.de\/en\/unternehmen\/biontech-small-molecules-gmbh\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.izb-online.de\/en\/"},{"@type":"ListItem","position":2,"name":"Startups im IZB","item":"https:\/\/www.izb-online.de\/en\/company-categories\/startups-en\/"},{"@type":"ListItem","position":3,"name":"BioNTech SE, Munich Small Molecules"}]},{"@type":"WebSite","@id":"https:\/\/www.izb-online.de\/en\/#website","url":"https:\/\/www.izb-online.de\/en\/","name":"Innovations- und Gr\u00fcnderzentrum Biotechnologie IZB","description":"Innovations- und Gr\u00fcnderzentrum Biotechnologie","publisher":{"@id":"https:\/\/www.izb-online.de\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.izb-online.de\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.izb-online.de\/en\/#organization","name":"F\u00f6rdergesellschaft IZB mbH","url":"https:\/\/www.izb-online.de\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.izb-online.de\/en\/#\/schema\/logo\/image\/","url":"https:\/\/www.izb-online.de\/wp-content\/uploads\/2020\/06\/izb-logo.svg","contentUrl":"https:\/\/www.izb-online.de\/wp-content\/uploads\/2020\/06\/izb-logo.svg","width":1,"height":1,"caption":"F\u00f6rdergesellschaft IZB mbH"},"image":{"@id":"https:\/\/www.izb-online.de\/en\/#\/schema\/logo\/image\/"}}]}},"gco_companies_contact_fax":"+49 (0)89\/818 8802-20","gco_companies_contact_fon":"+49 (0)89\/818 8802-0","gco_companies_contact_email":"info@biontech.de","gco_companies_contact_website_url":"https:\/\/www.biontech.de","gco_companies_contact_website_link_text":"www.biontech.de","gco_companies_contact_street":"Am Klopferspitz 19a","gco_companies_contact_zip":"82152","gco_companies_contact_city":"Planegg\/Martinsried","gco_companies_contact_country":"Germany","gco_companies_info_business_area":"Drug Discovery, Product Developer","_links":{"self":[{"href":"https:\/\/www.izb-online.de\/en\/wp-json\/wp\/v2\/gco_companies\/1480","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.izb-online.de\/en\/wp-json\/wp\/v2\/gco_companies"}],"about":[{"href":"https:\/\/www.izb-online.de\/en\/wp-json\/wp\/v2\/types\/gco_companies"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.izb-online.de\/en\/wp-json\/wp\/v2\/media\/13330"}],"wp:attachment":[{"href":"https:\/\/www.izb-online.de\/en\/wp-json\/wp\/v2\/media?parent=1480"}],"wp:term":[{"taxonomy":"company-categories","embeddable":true,"href":"https:\/\/www.izb-online.de\/en\/wp-json\/wp\/v2\/company-categories?post=1480"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}